FDA 483 - Xenova Sciences, LLC - September 12, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Xenova Sciences, LLC's API manufacturing facility in Gretna, NE, revealed significant deficiencies in quality control and CGMP compliance. Observations included failures in scientifically establishing sampling plans and test procedures for microbial control, and inadequate microbial testing in stability programs. The quality unit also failed to ensure CGMP compliance, with issues in batch record review, incomplete cleaning validation, and insufficient employee training documentation.
ID · d080cd32-7a08-4961-bf1f-4c82572af6fb